Illumina, Pacific Biosciences, Microsoft, and Monster Beverage were mentioned as thematic investing winners in the life sciences tools and services segment.
2 reports, 1 independent
Updated Aug 3
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Illumina, Pacific Biosciences, Microsoft, and Monster Beverage were mentioned as thematic investing winners in the life sciences tools and services segment.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Monster Beverage
American beverage company
- The article discusses the Federal Reserve, Jerome Powell's role as Chair, and market caution ahead of rate decisions, specifically mentioning Oxford Industries and Monster Beverage.
- Microsoft, Booz Allen Hamilton, ManpowerGroup, and Robert Half were mentioned in the context of thematic investing and their presence in the professional services segment.
-
Microsoft
American multinational technology corporation
-
Illumina
American company that develops systems for the analysis of genetic variation
-
Pacific Biosciences
biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation
Nothing else this week.
Related events
- Monster Beverage and Microsoft were cited as diverse winners in the banks segment in thematic investing on July 22, 2025, alongside Annaly Capital Management and Citigroup.
- Waste management companies Waste Connections and Quest Resource were mentioned alongside Microsoft as examples in thematic investing on August 10, 2025.
- Citigroup and Paychex were analyzed as investment opportunities on July 28, 2025.
- Iceland and Microsoft were noted for featuring advanced scientific technology.
Coverage
Newest first; wire copies grouped- StockStoryPacBio (PACB) Q2 Earnings Report Preview: What To Look For Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results this Thursday afternoon. Here’s what to